So, blah, blah, blah - we are pre-funding our R&D through what is effectively an overdraft facility.
So they are saying that their operating cash costs including R&D are $2.931 million, they sell $193k and get $984k back on rebate. Where is the other $1.754 million coming from in 23-24. They brought in $1.44 million of additional equity in 22-23 and have $293k in the bank at the end of year.
September quarter will be interesting to see if Peter can pull a magic rabbit out of his hat. I can't imagine trying to run a company that can't sell anything and trying to survive like these guys are. Maybe 23-24 will revive the pandemic?
SKN Price at posting:
0.7¢ Sentiment: Sell Disclosure: Not Held
